Insider Shareholders with Direct Ownership of Kura Oncology, Inc. (KURA)
This section provides a comprehensive overview of the insiders with direct ownership of Kura Oncology, Inc. (KURA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kura Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Teresa Brophy Bair
Chief Legal Officer |
69,375 | 6,768 | 68,979 $587,011 | 5 |
May 20, 2024
Reduced 3.65%
|
|
Thomas James Doyle
SVP, Finance & Accounting |
40,265 | 3,866 | 48,093 $409,271 | 5 |
Jan 29, 2024
Reduced 1.96%
|
|
Stephen Dale
Chief Medical Officer |
60,025 | 21,208 | 38,817 $330,332 | 5 |
Jan 30, 2024
Reduced 11.06%
|
|
Kathleen Ford
Chief Operating Officer |
43,775 | 25,718 | 23,184 $197,295 | 10 |
Nov 18, 2024
Reduced 2.22%
|
|
Marc Grasso
CFO, CBO |
21,900 | 0 | 21,900 $186,369 | 1 |
Jan 26, 2022
Added 50.0%
|
|
Kirsten Flowers
CCO & Chief Strategy Officer |
21,900 | 1,906 | 20,605 $175,348 | 2 |
Jan 27, 2023
Reduced 8.47%
|
|
Brian T. Powl
Chief Commercial Officer |
15,000 | 0 | 15,000 $127,650 | 1 |
Jan 02, 2024
Added 50.0%
|
|
Troy Edward Wilson
President and CEO |
157,863 | 187,959 | 559 $4,757 | 10 |
Jan 24, 2024
Reduced 99.34%
|